| 1.2 |
4.7 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.9 |
2.7 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.9 |
2.6 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.3 |
1.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.3 |
0.9 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.3 |
0.8 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 0.3 |
0.8 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.2 |
1.7 |
GO:0051461 |
positive regulation of heat generation(GO:0031652) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
0.5 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.2 |
0.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
2.8 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
1.0 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 |
0.8 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
2.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.7 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
1.2 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
1.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
1.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.7 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.2 |
1.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.8 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.5 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 |
1.8 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.1 |
0.6 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.5 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
2.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.4 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.3 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.1 |
1.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.8 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
1.7 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.8 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 |
0.7 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
0.3 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
1.8 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.2 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.1 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.4 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.1 |
0.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 |
0.5 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.4 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.4 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.9 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
0.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.1 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.4 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.4 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.3 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.2 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) negative regulation of PERK-mediated unfolded protein response(GO:1903898) positive regulation of receptor catabolic process(GO:2000646) |
| 0.0 |
0.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
1.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
1.1 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 |
0.4 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.0 |
0.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.0 |
0.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.3 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.7 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.2 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.0 |
0.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
1.0 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.9 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.0 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.0 |
0.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.9 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.0 |
0.5 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.6 |
GO:0050890 |
cognition(GO:0050890) |
| 0.0 |
0.5 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.0 |
1.0 |
GO:0001678 |
cellular glucose homeostasis(GO:0001678) |
| 0.0 |
0.3 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-dependent nucleosome organization(GO:0034723) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.7 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.0 |
0.2 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.9 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
